Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.
Chemistry Department, University of Rome "Sapienza", 00185 Rome, Italy.
Molecules. 2021 Jul 8;26(14):4167. doi: 10.3390/molecules26144167.
A new strategy that takes advantage of the synergism between NMR and UHPLC-HRMS yields accurate concentrations of a high number of compounds in biofluids to delineate a personalized metabolic profile (SYNHMET). Metabolite identification and quantification by this method result in a higher accuracy compared to the use of the two techniques separately, even in urine, one of the most challenging biofluids to characterize due to its complexity and variability. We quantified a total of 165 metabolites in the urine of healthy subjects, patients with chronic cystitis, and patients with bladder cancer, with a minimum number of missing values. This result was achieved without the use of analytical standards and calibration curves. A patient's personalized profile can be mapped out from the final dataset's concentrations by comparing them with known normal ranges. This detailed picture has potential applications in clinical practice to monitor a patient's health status and disease progression.
一种新策略利用 NMR 和 UHPLC-HRMS 之间的协同作用,可在生物流体中准确测定大量化合物的浓度,从而描绘出个性化的代谢谱(SYNHMET)。与单独使用两种技术相比,这种方法在代谢物的鉴定和定量方面具有更高的准确性,即使在尿液中也是如此,由于其复杂性和可变性,尿液是最具挑战性的生物流体之一。我们对健康受试者、慢性膀胱炎患者和膀胱癌患者的尿液进行了总共 165 种代谢物的定量分析,且数据缺失值最小。该结果是在不使用分析标准品和校准曲线的情况下实现的。通过将患者的个人资料与已知的正常范围进行比较,可以从最终数据集的浓度中描绘出患者的个性化图谱。这种详细的图谱在临床实践中有应用潜力,可以用于监测患者的健康状况和疾病进展。